- Home
- FT vs ME Comparison
FT vs ME Comparison
Compare FT & ME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FT
- ME
- Stock Information
- Founded
- FT 1988
- ME 2006
- Country
- FT United States
- ME United States
- Employees
- FT N/A
- ME N/A
- Industry
- FT Trusts Except Educational Religious and Charitable
- ME Precision Instruments
- Sector
- FT Finance
- ME Health Care
- Exchange
- FT Nasdaq
- ME Nasdaq
- Market Cap
- FT 185.7M
- ME 98.7M
- IPO Year
- FT N/A
- ME N/A
- Fundamental
- Price
- FT $7.29
- ME $3.39
- Analyst Decision
- FT
- ME Hold
- Analyst Count
- FT 0
- ME 1
- Target Price
- FT N/A
- ME $9.40
- AVG Volume (30 Days)
- FT 63.0K
- ME 219.4K
- Earning Date
- FT 01-01-0001
- ME 02-05-2025
- Dividend Yield
- FT 7.85%
- ME N/A
- EPS Growth
- FT N/A
- ME N/A
- EPS
- FT N/A
- ME N/A
- Revenue
- FT N/A
- ME $193,260,000.00
- Revenue This Year
- FT N/A
- ME $21.93
- Revenue Next Year
- FT N/A
- ME $17.31
- P/E Ratio
- FT N/A
- ME N/A
- Revenue Growth
- FT N/A
- ME N/A
- 52 Week Low
- FT $5.97
- ME $2.66
- 52 Week High
- FT $7.23
- ME $16.52
- Technical
- Relative Strength Index (RSI)
- FT 40.30
- ME 44.56
- Support Level
- FT $7.19
- ME $3.15
- Resistance Level
- FT $7.35
- ME $4.18
- Average True Range (ATR)
- FT 0.09
- ME 0.26
- MACD
- FT 0.00
- ME 0.05
- Stochastic Oscillator
- FT 43.75
- ME 29.46
About FT Franklin Universal Trust
Franklin Universal Trust is a closed-end management investment company. Its primary investment objective is to provide high, current income consistent with the preservation of capital. Its secondary objective is the growth of income through dividend increases and capital appreciation. The fund invests in two asset classes being the high yield bonds and utility stocks.
About ME 23andMe Holding Co.
23andMe Holding Co is a consumer-facing healthcare technology company, primarily involved in the sale of direct-to-consumer personal genome services, or PGS, through DNA collection kits shipped via mail. The company provides users access to reports summarizing estimated genetic ancestry breakdown, phenotypic trait reports, and various health predisposition and disease carrier reports. Its segment includes Consumer and Research Services and Therapeutics. The company generates maximum revenue from the Consumer and Research Services segment.